InvestorsHub Logo
Followers 16
Posts 1267
Boards Moderated 0
Alias Born 01/24/2015

Re: None

Tuesday, 10/09/2018 1:10:04 AM

Tuesday, October 09, 2018 1:10:04 AM

Post# of 27120
Granted there's never a straight MDTR apples to apples comparison but what do you all think about this apples to oranges test case?
Currently if we just look at market cap alone for another (as close as possible, in the same sector at least, 5B+ share structure) MJ-related company, MJNA is at about $300M and MDTR is at $125M. That means to be equivalent MDTR can go to 2.4x current price to match market cap 1:1. Digging into the financials, while both co's have sales MJNA has $2M loss which puts it worse than MDTR. Even with losses MJNA has been as high as $660M market cap (an equivalent of 5.28x MDTRs current share price). So a realistic range that is achievable as demonstrated by another company is $.0548 (2.4x) to $.1204 (5.28x) since MDTR is in a better position and showing better COGs ratio, business model, and is a prime candidate for acquisition...? Seems like a dime is well within the reach of MDTR if/when the right storm conditions lines up.

All IMO of course. But looking for long target points. What say all of you???